Click to Share

Ataxia Press Releases

Exclusive News
Topics Locations Industries Dates

A research team specialized in the study of nervous system disorders has found that NLX-112, a serotonin 5-HT1A receptor agonist developed by Neurolixis, reversed motor deficits in a transgenic model of Spinocerebellar ataxia3 (SCA3), a rare genetic...

Page updated every 10 minutes

Like PRLog?
Click to Share